BG105779A - Човешки антибиотични протеини - Google Patents

Човешки антибиотични протеини

Info

Publication number
BG105779A
BG105779A BG105779A BG10577901A BG105779A BG 105779 A BG105779 A BG 105779A BG 105779 A BG105779 A BG 105779A BG 10577901 A BG10577901 A BG 10577901A BG 105779 A BG105779 A BG 105779A
Authority
BG
Bulgaria
Prior art keywords
proteins
antibiotic proteins
human antibiotic
sap
utilization
Prior art date
Application number
BG105779A
Other languages
Bulgarian (bg)
English (en)
Inventor
Enno Christophers
Jurgen Harder
Jens Schroder
Original Assignee
Enno Christophers
Jurgen Harder
Jens Schroder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19905128A external-priority patent/DE19905128A1/de
Priority claimed from DE1999149436 external-priority patent/DE19949436A1/de
Application filed by Enno Christophers, Jurgen Harder, Jens Schroder filed Critical Enno Christophers
Publication of BG105779A publication Critical patent/BG105779A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BG105779A 1999-02-01 2001-08-03 Човешки антибиотични протеини BG105779A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19905128A DE19905128A1 (de) 1999-02-01 1999-02-01 Humane antibiotische Proteine
DE1999149436 DE19949436A1 (de) 1999-10-08 1999-10-08 Mindestens zwei humane antibiotische Proteine
PCT/EP2000/000776 WO2000046245A2 (fr) 1999-02-01 2000-02-01 Proteines antibiotiques humaines

Publications (1)

Publication Number Publication Date
BG105779A true BG105779A (bg) 2002-04-30

Family

ID=26051733

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105779A BG105779A (bg) 1999-02-01 2001-08-03 Човешки антибиотични протеини

Country Status (8)

Country Link
US (2) US7419781B1 (fr)
EP (1) EP1068232B1 (fr)
AT (1) ATE291586T1 (fr)
AU (1) AU2668400A (fr)
BG (1) BG105779A (fr)
CA (1) CA2371794C (fr)
DE (1) DE50009838D1 (fr)
WO (1) WO2000046245A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576755B1 (en) 1997-09-10 2003-06-10 Zymogenetics, Inc. Beta-defensins
ATE291586T1 (de) * 1999-02-01 2005-04-15 Schering Ag Humanes antibiotisches protein
AU2001275208A1 (en) 2000-06-01 2001-12-11 University Of Iowa Research Foundation Human beta-defensin-3 (hbd-3), a highly cationic beta-defensin antimicrobial peptide
CA2427066A1 (fr) * 2000-07-11 2003-02-24 Ipf Pharmaceuticals Gmbh Methode de recuperation et d'application des defensines humaines comme proteines biologiquement actives pour le traitement des infections et d'autres maladies
WO2002040512A2 (fr) * 2000-11-14 2002-05-23 Ipf Pharmaceuticals Gmbh Beta-defensine-3 humaine
FR2879203A1 (fr) * 2004-12-09 2006-06-16 Univ Rennes I Etablissement Pu Peptides antimicrobiens, polypeptides comprenant lesdits peptides, procedes pour les preparer, genes codant pour lesdits peptides, vecteurs, organismes transformes et compositions les contenant
MX2007011356A (es) 2005-03-18 2008-03-10 Domantis Ltd Anticuerpos contra antigenos de candida.
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
EP2399618A1 (fr) * 2010-06-22 2011-12-28 Planton GmbH Instruments médicaux antimicrobiels
US20150072922A1 (en) * 2012-04-17 2015-03-12 The Research Institute At Nationwide Children's Hospital Rnase 7 antimicrobial peptides
US11744859B2 (en) 2017-07-07 2023-09-05 Epicentrx, Inc. Compositions and methods for parenteral administration of therapeutic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08507702A (ja) 1993-01-12 1996-08-20 エム． ニューマン，ナンシー 見分けられない包帯アセンブリ
US5866119A (en) 1997-06-02 1999-02-02 Incyte Pharmaceuticals, Inc. Human ribonuclease
AU744152B2 (en) 1997-09-10 2002-02-14 Zymogenetics Inc. Beta-defensins
EP0943679A1 (fr) 1998-03-13 1999-09-22 Innogenetics N.V. Nouvelle protéine de type ribonuclease et son utilisation
ATE291586T1 (de) 1999-02-01 2005-04-15 Schering Ag Humanes antibiotisches protein

Also Published As

Publication number Publication date
US7419781B1 (en) 2008-09-02
DE50009838D1 (de) 2005-04-28
CA2371794C (fr) 2013-10-29
WO2000046245A8 (fr) 2001-03-22
AU2668400A (en) 2000-08-25
US20090010996A1 (en) 2009-01-08
EP1068232B1 (fr) 2005-03-23
WO2000046245A3 (fr) 2000-11-23
WO2000046245A2 (fr) 2000-08-10
EP1068232A2 (fr) 2001-01-17
CA2371794A1 (fr) 2000-08-10
ATE291586T1 (de) 2005-04-15
US8735097B2 (en) 2014-05-27

Similar Documents

Publication Publication Date Title
YU51095A (sh) Benzokazolil - i benzotiazolil-oksazo lidinoni
PT911340E (pt) Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos
EE200100257A (et) Uudne membraan või maatriks ravimi läbitungimise kontrollimiseks
ATE320457T1 (de) Polyurethanlösungen mit alkoxysilanstruktureinheiten
ZA200300788B (en) Improvements in and relating to the use of honey in dressings.
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
DE69630947D1 (de) Mittel zur schmerzbehandlung
ID22878A (id) Komposisi aktif secara terapi
NO963239D0 (no) Klorpyrimid-mellomprodukter
DE69901177D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
DE69937562D1 (de) Verbessertes angereichertes blutplättchen wundheilmittel
PT1169460E (pt) Preparacao de moleculas biologicamente activas.
NO20005179D0 (no) Medikament behandling
BG105779A (bg) Човешки антибиотични протеини
TR199900548A3 (tr) Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi.
DE69532485D1 (de) Trehalose-freisetzendes Enzym, dafür kodierende DNA, Herstellung und Verwendung
EE9800451A (et) Uued imidasotriasolopürimidiinid, nende valmistamismeetod ja kasutamine ravimainetena
PT1214302E (pt) 3-fenil-5-alcoxi-1,3,4-oxadiazol-2-onas substituidas e sua utilizacao como inibidores de lipase
EP1038958A4 (fr) PROTEINE Nap1 HUMAINE
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
IT1284920B1 (it) Trattamento del diamante
FI971872L (fi) Proteiinikoostumus ja sen valmistus ja käyttö sekä sitä sisältävät valmisteet ja näiden valmistus
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
PT1235809E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocinas substituidas e sua utilizacao como medicamentos